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A B S T R A C T
Background: Leucine rich Aspartate motifs (LD motifs) are molecular recognition motifs on Paxillin that re-
cognize LD-motif binding domains (LDBD) of a number of focal adhesion proteins in order to carry out down-
stream signaling and actin cytoskeleton remodeling. In this study, we identified structural features within LDBDs
that influence their binding affinity with Paxillin LD motifs.
Methods: Various point mutants of focal adhesion targeting (FAT) domain of Focal Adhesion Kinase (FAK) were
created by moving a key Lysine residue two and three helical turns in order to match the unique conformations
as observed in LDBDs of two other focal adhesion proteins, Vinculin and CCM3.
Results: This led to identify a mutant of FAT domain of FAK, named as FAT(NV) (Asn992 of FAT domain was
replaced by Val), with remarkable high affinity for LD1 (Kd=1.5 μM vs no-binding with wild type) and LD2
peptides (Kd= 7.2 μM vs 63 μM with wild type). Consistently, the focal adhesions of MCF7 cells expressing FAK
(NV) were highly stable (turnover rate= 1.25×10−5 μm2/s) as compared to wild type FAK transfected cells
(turnover rate= 1.5× 10−3 μm2/s).
Conclusions: We observed that the relative disposition of key LD binding amino-acids at LDBD surface, hydro-
phobic burial of long Leucine side chains of LD-motifs and complementarity of charged surfaces are the key
factors determining the binding affinities of LD motifs with LDBDs.
General significance: Our study will help in protein engineering of FAT domain of FAK by modulating FAK-LD
motif interactions which have implications in cellular focal adhesions and cell migration.
1. Introduction
Paxillin is a 68 kDa scaffold protein with four LIM domains at its C-
terminus [1,2]. The N-terminus of Paxillin is highly disordered and
contains structural motifs rich in Leucine and starting with Leucine and
Aspartate residues, hence named Leucine rich Aspartate motifs (LD
motifs) [3,4]. The LD motifs have a conserved sequence motif LDxLLxxL
that folds as an amphipathic alpha helix [3]. Five LD motifs are present
at Paxillin N-terminus and they are named from LD1 to LD5 in the order
they are located on Paxillin sequence. While the knowledge on binding
partners for LD3 and LD5 motifs is limited [5,6], other LD motifs (LD1,
LD2, LD4) play an important role in focal adhesion biology as many of
the structural and signaling molecules are localized to focal adhesions
(FAs) through interaction with LD motifs [3,7]. Moreover, they com-
pete with other similar LD-like motifs and thus regulate cell migration
[8].
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Sequences similar to LD motifs have been identified in several other
proteins [4,9] however their function and binding partners remain
unknown. Recently, LD-like motifs were identified in Cerebral Ca-
vernous Malformations (CCM2) [10], Rho GTPase activating protein
called Deleted in Liver Cancer1 (DLC1) [11] and in an intrinsically
disordered translocated actin recruiting phosphoprotein (TarP) of
Chlamydia [12]. The LD-like motif of CCM2 helps in mediating domain
interaction with CCM3 to protect the proteins from proteasomal de-
gradation [10]. Chlamydia TarP LD motif competes with mammalian
Paxillin LD motif for interaction with Focal adhesion Kinase (FAK)
leading to focal adhesion formation and thus cellular migration [12].
Similar competitive behavior is identified for the LD-like motif of DLC1,
a tumor suppressor RhoGAP protein [11]. Similar to Paxillin LD motif,
the DLC1 LD-like motif binds Talin and FAK and has been shown to be
required for full tumor suppressor activity of DLC1 [11,13]. Thus, LD
motifs are emerging as an important class of protein-protein interaction
motifs implicated in host pathogen interactions, cancer metastasis, and
brain disorders.
The protein domains that exhibit affinity for LD motifs (LD motif
binding domains, LDBDs) have variable sequence and structural fold
[14]. Most of them fold into a typical alpha-helical bundle [15], how-
ever there are exceptions from this trend such as α-parvin [16] and BPV
E6 protein, which have two Zinc fingers [17]. LD motifs recognize a
number of focal adhesion proteins, such as FAK [18], GIT [19], Pyk2
[20,21], Vinculin [22–24], β-parvin [25], Talin [13], Integrin [26],
Kindlin-2 [27] and non-focal adhesion proteins such as CCM3 [7,28].
Same LD motif can bind to various LDBDs with varying affinities.
For example, LD4 binds with high affinity to Focal adhesion targeting
domain of Focal adhesion kinase (FAKFAT), but with low affinity to
CCM3 [28]. Similarly, LD1 shows high affinity for CCM3 (Kd: 17 μM)
[28], while it does not bind FAKFAT domain. LDBDs also bind selec-
tively to certain LD motifs although the key interacting residues remain
the same. For example, FAKFAT binds strongly with LD4 but does not
interact with LD1. Various factors such as presence of conserved
flanking residues near core LD motifs, variations within LD motifs, and
length of LD motifs are suggested to influence the strength of LD-motif
interaction with LDBDs. The variations in binding affinity range from
no binding to as high as 1 μM [28]. In this study, we scrutinized the key
elements critical for determining the binding affinity of LD motifs with
LDBDs by analyzing available crystal structures, docking and iso-
thermal titration calorimetry (ITC). Subsequently, the results were
verified by cell-based experiments. We identify the hitherto unknown
conformational requirement of key interacting amino acids and their
relative positions.
2. Materials and methods
2.1. Sequence alignments and phylogenetic tree
Sequences of Paxillin, Hic5, PaxB and Leupaxin from Dictyostellium,
Drosophila, Gallus, Xenopus, Danio and human were obtained from NCBI
database and aligned by ClustalX v2.1 [29]. The LD motif sequences
from Gelsolin, CCM2, DLC1, DLC2, RoXaN, Clamydia and others from
the literature [4,10,12,14] were also added to the dataset. The phylo-
genetic tree was predicted using the neighbor-joining method [30],
1000 bootstrap trials and was displayed using iTOL online server [31].
2.2. Retrieving and analyzing three dimensional structures from Protein
Data Bank
Three dimensional atomic coordinates of LD binding domains of
FAKFAT (PDB ID: 1OW6, 1OW7, 1OW8) [32], CCM3 (PDB ID: 3RQE,
3RQF, 3RQG) [28], α-parvin (PDB ID: 2VZD, 2VZG, 2VZI) [16] in
complex with LD1, LD2, and LD4 peptides were retrieved from RCSB
Protein Data Bank (PDB) [33]. PDB file corresponding to Vinculin tail
domain (PDB ID: 3H2U) [34] was also extracted, although it is not in
complex with any LD motif. Supplementary Table S1 summarizes the
structures obtained and analyzed for LD motif binding and those that
bind to LD motifs.
‘Contact’ module available as part of CCP4 suite of programs was
used to identify atomic contacts falling below a cut-off distance of 4 Å.
No contacts of hydrogen atoms were included in the calculation.
Hydrophobic interactions were estimated by counting the number of Cα
atom pairs from two chains. Electrostatic interactions were the inter-
actions between two electronegative atoms from two separate chains.
2.3. Molecular docking using HADDOCK
LD1, LD2 and LD4 peptides were extracted from α-parvin-LD com-
plexes (from PDB IDs: 2VZD, 2VZG and 2VZI respectively) [16]. These
were docked on LDBDs of FAK (PDB ID: 1OW6), CCM3 (PDB ID: 3RQG)
and Vinculin (PDB ID: 3H2U) [15,28,35]. In silico mutations were in-
troduced using Python molecular viewer (PMV) [36] without further
energy minimization of mutants. HADDOCK webserver with expert
access (http://haddock.science.uu.nl/enmr/services/HADDOCK2.2/
haddockserver-expert.html) was used for calculating restrained
docking solutions [37]. Ambiguous restraints were taken as residues
within 4 Å from any atom of the peptide in LDBD. This allowed ex-
ploring more interactions on the defined surface. Unambiguous dis-
tance restraints (UIRs) were defined for active residues that make
conserved interactions. For example, Asp of LD motifs is always ob-
served to interact with Arg or Lys residue in LDBDs. This restraint en-
sures that the LD peptides dock in the correct orientation and not in an
inverted direction. List of residues taken to define ambiguous and Un-
ambiguous distance restraints is given in Supplementary Table S3.
Passive residues were defined automatically around active residues. No
center of mass restrains and surface contact restraints were given. De-
fault protonation states were taken for all Lys and Arg residues. AIR is
an ambiguous distance between a pair of amino acid residues shown to
be involved in a particular protein-protein interaction [38].
1000 iterations of rigid-body docking, each with five trials of energy
minimization followed by semiflexible and explicit solvent refinements
were carried out on top 200 structures with the lowest energy.
HADDOCK score is calculated as the weighted sum of van der Waals
(Evdw), electrostatic energy (Eelec), restraints violation energy (Edist),
and desolvation energy (Edesol) in kcal/mol [37]. Docking solutions
were clustered based on a 2 Å r.m.s.d. cut-off. Each cluster was scored
based on the top five structures of the lowest energy set. Images were
displayed by PyMOL (The PyMOL Molecular Graphics System, Version
1.5.0.1 Schrödinger, LLC).
2.4. Molecular cloning
The Focal adhesion targeting domain of Chicken Focal adhesion
kinase (amino acid: 905–1053) was sub-cloned from a full length con-
struct into a 6His-tag containing modified pET-M vector between
BamH1 and Xho1 sites. The following primer sequences were used;
forward primer: GCGGATCCATCAAGCCACAGGAAATC, reverse primer:
GCCTCGAGTTAGTGGGGCCTGGACTG. Double point mutations were
introduced in the wild type construct by site directed mutagenesis using
following primer sequences: (N992K, K989V): GGCCCAGGTACTGCTG
AAGTCTGACC (forward primer), (N992K, K989 N): GGCCCAGAATCT
GCTGAAGTCTGACC (forward primer). The mutated DNA was trans-
formed into E.coli XL1-blue cells and plated on antibiotic containing
agar plate. The correct in-frame mutations were confirmed by sequen-
cing of selected clones.
2.5. Protein expression and purification
The modified pET32a plasmids were transformed into E.coli BL21
(DE3) cells. The cells were grown in LB broth at 37 °C. Once the optical
density of the culture was 0.3–0.5, the protein expression was induced
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by adding 1mM IPTG. The cells were harvested by centrifugation and
resuspended in 20mM Tris-HCl (pH 8), 200mM NaCl, 5 mM DTT, 1%
TritonX-100, 5% glycerol and protease inhibitor (Roche). The cells were
lysed by sonication of the cell suspension on ice. The lysates were
centrifuged and the supernatant was transferred to previously washed
Ni-NTA beads for overnight binding. After three washes, the protein
was eluted from beads in two elution steps. The elution buffer had
20mM Tris-HCl (pH 8), 150mM NaCl, 5% glycerol and 5mM DTT in
addition to 200–300mM Imidazole. The eluted protein was loaded on
pre-equilibrated Superdex75 column for further purification by size
exclusion chromatography. The fractions were collected and were
stored in 20mM Tris-HCl (pH 8) and 150mM NaCl. The homogeneity of
the protein was assessed by dynamic light scattering and SDS-PAGE
(Supplementary Fig. S5).
2.6. Isothermal titration calorimetry
All ITC titrations were performed on a VP-ITC calorimeter
(MicroCal, LLC, Northampton, MA, USA) at 25 °C. The reference cell
was filled with the same buffer solution as that used for the protein.
Peptides of grade > 98% purity were purchased from GL Biochem
(Shanghai) Ltd. and used without further purification. The sequences of
the peptides were as follows; LD1: MDDLDALLADLEST, LD2: LSELDR-
LLLELNAV, LD4: TRELDELMASLSDF. These included the consensus LD
motif sequence, as underlined, together with three additional amino
acids at both N- and C-terminus. The sample cell of the micro-calori-
meter was cleaned thoroughly. 40–50 μM protein, purified by gel fil-
tration in 20mM Tris (pH 8) and 150mM NaCl, was placed in the
sample cell, and was titrated with 0.9–1mM peptide solution prepared
freshly in identical buffer as that of the protein. The samples were
subjected to high speed spin for 5min and degassed prior to titrations.
Heats given by injections, each of 10 μL volume, were recorded at
equally spaced intervals of seven minutes. The heat effects per injection
were calculated by integration and were normalized by the amount of
LD peptide added per injection. All titrations were analyzed with a
model considering ‘n’ identical and independent ligand binding sites
implemented in Origin 7.0 (Origin Lab Corp., Northampton, MA, USA)
software. There is no need for assuming a model considering non-
identical binding sites or cooperative binding sites (with one exception,
discussed in results). At least two replicates for each experiment were
performed (Supplementary Fig. S2). Statistical parametric (F-test) and
non-parametric (Akaike's Information Criterion) tests have been applied
in order to compare the statistical performance of binding models, re-
garding mainly the number of binding-competent binding sites. The
results (binding affinity, stoichiometry) shown in Table 3 and Supple-
mentary Table S5 represent the most appropriate results according to
these comparison tests.
2.7. Cell culture, transfection and imaging
MCF7 cells were grown in high-glucose DMEM (Hyclone), 10% fetal
bovine serum, 100 units/mL penicillin, and 100 μg/mL streptomycin
(Hyclone). The cells were grown at 37 °C and 5% CO2. MCF7 cells were
seeded in 6-well plates and were transfected with 1 μg of wild type and
mutated FAK plasmids using Mirus (TransIT). 35mm glass bottom
culture dish (Ibidi) were coated with 10 μg/cm2 of rat tail collagen Type
I (Sigma) for 1 h at 37 °C. 104 of MCF7 cells were trypsinized and seeded
on a glass bottom dish for 5min and imaged using a spinning disk
confocal microscope (PerkinElmer) at 37 °C, 5% CO2. The images were
background subtracted and analyzed with the image analysis software,
Imaris (Bitplane). The region of Interest (i.e. focal adhesion) was
masked. Autoregressive motion was used to track the changes in the
area over the indicated time points. A change in area of at least 95 focal
adhesions over a period of 40 mins was quantified for each sample. The
values were plotted, and statistical significance of the data was calcu-
lated by unpaired t-test with Welch's Correction using GraphPad Prism
version 6.0c for Mac, GraphPad Software, La Jolla California USA. The
Welch's t-test, or unequal variances t-test was used to determine the
asymptotic significance of the data as an adaptation of Student's t-
test,due to its higher reliability when the two samples have unequal
variances and/or unequal sample sizes.
3. Results
3.1. LD motifs and their conservation across organisms
We first constructed a cladogram using 14-mer LD motif sequences
of Paxillin, Hic5, Leupaxin, PaxB and other proteins from the literature
[4,10,12,14] (Fig. 1). They were identified from Human, Xenopus,
Danio, Dictyostelium, Gallus and Drosophila genomes to make the dataset
more comprehensive. Broadly, the tree showed clustering in five dis-
tinct groups named as LD1 to LD5 (taking human Paxillin as reference).
Unconventional LD motifs, such as DLC1-LD, do not cluster with any of
these groups. On the basis of clustering, we propose that they might
exhibit different binding properties with typical LDBDs. Thus, LD motifs
also form an important class of protein recognition motifs.
PaxB isoform is closer to slime mold Paxillin sequence. The con-
ventional LD1, LD2, and LD4 motifs are slow evolving as compared to
LD3 and LD5. The LD motifs of Calretinin, Calbinding, and β-adaptin,
which cluster closely to LD1 motif branch, can be explored for their
ability to interact with typical LDBDs that provide grove between he-
lices for LD binding. The LD motif of pathogen Chlamydia was closely
related to LD5 motif for which no LDBD has been identified yet. Thus,
knowledge of more divergent LDBDs will help to understand host-pa-
thogen relations. Similarly, RoXaN clustered most closely with di-
vergent LD motifs of Deleted in Liver Cancer (DLC) protein, which is
known to interact with Talin and FAK [11,13] . Further, the greater
Fig. 1. Phylogenetic tree of LD motifs.
Neighbor-joining tree created using 14-mer LD-peptides taken from Paxillin,
PaxB, Hic-5 and Leupaxin sequences of Human, Gallus, Drosophila, Xenopus,
Danio, Dictyostellium is shown. The LD motif sequences were also taken from
CCM2, Chlamydia, DLC1, DLC2, RoXaN, Gelsolin and from literature
[4,10,12,14]. Branches were colored to show various clusters. Five distinct
groups corresponding to LD1 (red), LD2 (green), LD3 (orange), LD4 (blue), and
LD5 (purple) motifs were clearly differentiated from other unconventional LD
motif such as from Chlamydia and proteins other than Paxillin or its homo-
logues. The tree is displayed using iTOL [31].
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number of LD motifs in higher species might be related to evolving
versatility of such LD motifs.
3.2. LD motif binding domains (LDBDs)
A number of domains are known to bind to LD motifs
(Supplementary Table S1), however, no conserved sequence motif is
known for LD motif binding. To understand the key determining factors
for binding affinity, we first analyzed the available crystal structures of
FAKFAT domain in complex with LD motifs [15] and compared them
with LD bound complexes of CCM3 [28] and α-parvin [16]. To date,
these are the only three dimensional structures available in complex
with all three LD motifs (LD1, LD2, LD4) except FAKFAT which is not
known to bind with LD1. To assess hydrophobic burial, we counted the
number of C-C contacts between any of C-atom of LDBD and that of LD
motif within 4 Å using CCP4 suite, and also calculated the average C-C
distances [39]. Similarly, the number of electrostatic interactions (de-
fined as any two atoms with opposite partial charges belonging to se-
parate chains within 4 Å) were calculated (Table 1). We found that the
number of C-C contacts as well as C-C distances were not significantly
different among three structures. The distances range from 3.6 Å to
3.9 Å. The higher number of C-C interactions in α-parvin-LD1 and α-
parvin-LD4 (22 and 27 respectively) indicate that hydrophobic burial is
the main driving force for their interaction. Further, for a given struc-
ture, the number of electrostatic interactions were similar when com-
pared across three LD motifs. Thus, we conclude that neither the
number of hydrophobic nor the number of electrostatic interactions
determine specificity of three LD motifs towards LDBDs.
On binding surface of LDBDs, a few key residues have been marked
to be important for LD binding in earlier studies [15], e.g. Arg/ Lys,
which interact via salt bridge interaction with the Asp/ Glu of LD
motifs. A closer look of the binding surface of FAKFAT (PDB ID: 1OW6),
CCM3 (PDB ID: 3RQG) and Vinculin tail domain (PDB ID: 3H2U) re-
vealed that such interacting Arg/ Lys residues were present in unique
arrangement at four positions on these LDBDs. These positions were
named as pos1-pos4 (Table 2, Supplementary Fig. S6). In FAKFAT
(PDBID: 1OW7), these positions are occupied by R962 (pos1), K955
(pos2), K1002 (pos3), K988 (pos4) residues. The distances between the
Cα atoms of these residues were same in all three LDBDs, e.g. pos1 and
pos2 were separated by ~10 Å distance and two helical turns. Only the
Lys residue at pos4 was present at variable distances in three structures,
i.e. two, three and four helical turns apart from pos3 in CCM3, FAK and
Vinculin LDBDs respectively (Table 2). Thus, we created various mu-
tants by changing the position of Lysine at pos4 in all three structures to
mimic the LD binding surface of FAK, Vinculin and CCM3 LDBDs, in
order to analyze the effect of relative position of Lysine on binding
affinity. Since LD4 motif specifically binds only between helix2 and
helix3 of FAKFAT [32], we did not mutate other LD binding site be-
tween helix1 and helix4 known in FAKFAT. Further, the geometrical
features observed for site between helix1 and helix4, were not com-
parable to common features observed for FAT (helix2-helix3 site),
CCM3 and Vinculin (Fig. 2, Supplementary Fig. S6).
3.3. LD-FAKFAT docking analysis
We created in-silico mutants of FAKFAT (PDB ID: 1OW6), CCM3
(PDB ID: 3RQG), and Vinculin tail (PDB ID: 3H2U) domains by residue
swapping. For example, the Lys at pos4 (K988) in FAKFAT was swapped
with residue at one helical turn (N991) and two helical turns (G995) so
as to match the geometrical arrangements observed in Vinculin tail and
CCM3 LDBDs respectively. These were named as FAT(V-like) and
FAT(C-like) arrangements. The FAT(F-like) geometry refers to the ar-
rangement of residues found in wild type FAKFAT domain. In Vinculin
tail, the poorly defined LD motif binding surface is masked by a largely
hydrophobic N-terminal helix. This helix was deleted to expose the LD
motif binding surface for docking experiment. Similarly, Vinculin(C-
like) and Vinculin(F-like) mutants were created by swapping K924 with
L928, and A921 respectively in Vinculin tail domain. For CCM3, K172
was moved one helical turn to swap with V168 so as to match geo-
metrical arrangement observed in Vinculin tail (CCM3(V-like) mutant).
The CCM3(F-like) arrangement was same as wild type CCM3, as it has
Lysine at both positions. Residues restraints were given to explore
docking on desired binding surfaces. For example, FAKFAT has two
binding sites and LD1 binds CCM3 in opposite orientation as compared
to LD2 and LD4. Restraints restricted binding to a given site of FAKFAT
and known orientation of LD1 in CCM3. The values were compared
with their known lowest affinity LDBD. The C-like conformations in all
three LDBDs showed increased buried surface area and lower electro-
static energy. Based on this we concluded that changing the position of
Lysine improved the binding of LD motifs with their known lowest af-
finity LDBD (Supplementary Table 4).
3.4. Isothermal titration calorimetry
Homogenous fractions of purified wild type and mutant Gallus
FAKFAT domains were titrated with three LD motifs. Gallus FAKFAT
has A996 at pos4−2 instead of G995 of human FAKFAT (analyzed in
docking). We first created two C-like mutants named as FAT(AKKV) and
FAT(A996K). Similar to CCM3, FAT(A996K) mutant had Lysine at both
pos4−2 and pos4. FAT(AKKV) was a double mutant (A996K and
K989V) in which Alanine was replaced by Lysine two helical turns
above to match CCM3 configuration. The Lysine at pos4 was replaced
Table 1
Number of hydrophobic and electrostatic interactions within a cut-off distance of 4 Å in structures of FAKFAT, CCM3 and α-parvin with three LD motifs.
Domain peptide pairs PDB ID No. of C-C contacts Average C-C distance (Å) No. of electrostatic interactions Residues involved in electrostatic interactionsa
FAKFAT-LD2b 1OW8 16 3.65 7 Arg962, Lys955, Lys1002
FAKFAT-LD4 1OW7 15 3.63 6 Arg962, Lys955, Lys1002
CCM3-LD1 3RQE 16 3.74 3 Lys139,Lys132
CCM3-LD2 3RQF 14 3.81 3 Lys179,Lys172
CCM3-LD4 3RQG 19 3.81 4 Lys179, Lys172,Ser175
α-parvin-LD1 2VZD 22 3.79 6 Arg369,Lys260
α-parvin-LD2 2VZG 17 3.78 4 Arg369
α-parvin-LD4 2VZI 27 3.85 4 Arg369
a Only those residues are listed which made electrostatic contacts through their side-chain atoms.
b FAT domain of FAK does not bind with LD1.
Table 2
Geometric features between residues at pos3 and pos4 for various LDBDs.
LDBDs aDistance (Å) aNumber of turns
FAKFAT 21.3 4
Vinculin tail 17.5 3
CCM3 10.7 2
a The corresponding positions are pos4–1 and pos4–2 for Vinculin tail and
CCM3 respectively.
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by Valine to make it hydrophobic without major compromise in side
chain length (Fig. 2). In another set of mutants named as FAT(NKKV)
and FAT(NKKN), the configuration was matched to Vinculin tail. In
FAT(NKKV) mutant, N992 at pos4−1 was replaced by Lysine and Lysine
at pos4 was replaced with Valine while in FAT(NKKN) mutant, Lysine
and Asparagine residues at pos4 and pos4−1 were swapped so as to
maintain the overall charge at the binding surface.
In our experiments, the wild type domain could interact with LD2
and LD4 with 63 μM and 71 μM dissociation constants, respectively, and
two binding sites were observed as expected. The values observed are
different as compared to earlier studies because of different experi-
mental conditions and different length of peptide used. LD1 motif does
not bind to wild type domain (Fig. 3, Table 3). For both FAT(A996K)
and FAT(AKKV) mutants LD1 exhibited very low affinity (Kd≥500 and
400 μM respectively) (Supplementary Fig. S1 and Supplementary Table
S5). LD2 and LD4 could interact with these mutants with comparable
affinity as wild type, however, the stoichiometry of binding changed
from two binding sites to one binding site. LD4, showed a slight im-
provement in binding affinity to A996K mutant (Kd= 58 μM) as com-
pared to wild type (Supplementary Table 5). The result indicated that
the binding surface near pos4 affects the binding affinity for three LD
peptides, but the differences were not found to be very large.
The V-like mutants, i.e. FAT(NKKN) and FAT(NKKV), showed re-
markable improvement in Kd values. The stoichiometry of binding also
changed to one in both the mutants and with all three peptides. LD2
and LD4 showed five-fold and seven-fold stronger binding to swap
mutant FAT(NKKN) as compared to wild type. LD1 could bind with
48 μM dissociation constants as compared to no binding with wild type
domain. The binding was even stronger when Lysine at pos4 is mutated
to hydrophobic residue Valine (FAT(NKKV) mutant) with Kd value of
9.1 μM for LD1. LD2 peptide binds 2.4 times stronger, while a small
change in Kd value was observed for LD4 interacting with FAT(NKKV)
mutant. This indicates that LD1 significantly preferred FAT(NKKV)
mutant, while FAT(NKKN) mutant was favored for binding of LD2 and
LD4. The results strongly indicated that residues at pos4 of binding
surface in LDBD are key factors modulating and controlling the binding
affinities of LD peptides with LDBDs. Further, to test the preference for
a hydrophobic residue at pos4, we mutated N992 at pos4−1 to V, while
keeping Lys at pos4 unchanged (named as FAT(NV) mutant). Notably,
the dissociation constant of LD1 peptide with FAT(NV) mutant was
1.5 μM as compared to no binding with the wild type FAT domain. LD2-
peptide showed nine-fold stronger binding (7.2 μM), while LD4 did not
interact with FAT(NV) mutant. We conclude that LD1 peptide prefers a
hydrophobic residue at pos4 or pos4−1. Our mutants are especially
important since LD1 is unknown to bind FAT domain of FAK and we
could identify a single point mutant FAT(NV) with high affinity (Figs. 2,
3).
In all interactions tested, except in the case of FAT(NV) with LD2,
there was no need for considering two non-identical binding sites or
cooperative binding sites; the model considering a single set of identical
and independent binding sites (with n= 1 or n=2) was sufficient for
reproducing the experimental data. In fact, imposing two different
binding sites (with different binding affinity) or imposing a single
binding site in some cases (e.g., FAT(WT) titrated with LD2 and LD4)
resulted in either no convergence or dependence between fitting
parameters (when considering two different binding sites) or a re-
markably poor fitting (much larger chi-square). One of the assays for
FAT(NV) interacting with LD2 could be fitted either by considering a
single binding site and a concentration dependent background injection
heat or considering two different binding sites. The first case is the most
appropriate, according to a non-parametric model comparison statis-
tical test (Akaike's Information Criterion) (results shown in Table 3),
whereas in the second case the first site would exhibit two-fold higher
affinity than that reported in Table 3, and the second binding site would
have approximately ten-fold lower binding affinity. Both cases how-
ever, are suggestive of stronger affinity with FAT(NV). The other re-
plicate of FAT(NV) interacting with LD2 shown in Supplementary In-
formation clearly indicates the presence of a single binding site
(Supplementary Fig. S2).
3.5. Cell based experiments
Next, we sought to understand the physiological relevance of the
wild-type and high affinity mutants of the FAT domain of FAK. We
examined the turnover rate of focal adhesions of MCF7 cells expressing
the GFP-tagged wild type, FAK(NV), FAK(NKKV) and FAK(NKKN)
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C-like
NKKN NKKV
pos4
pos4-1
pos4-2
K
N
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N
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Fig. 2. FAKFAT mutants.
Four positions found to be critical for binding with LD motif
are shown on Focal adhesion targeting domain of Human
Focal Adhesion Kinase (FAKFAT). They are occupied by
Arg962 (pos1), Lys955 (pos2), Lys1002 (pos3) and Lys988
(pos4) residues in Gallus FAKFAT. Pos3 and pos4 are sepa-
rated by four helical turns in FAKFAT domain. The wild type
residues are shown in red and mutated ones in blue. (b) The
Lys988 residues was moved to pos4−2 to match geometric
arrangement as seen in CCM3, thus named C-like mutants. (c)
The other pair of mutant is named V-like where Lys988 was
moved one helical turn towards pos3. (d) Only Asn992 was
mutated with Valine while conserving the positions of
Lysines. Thus, the geometrical arrangement is similar to wild
type. The mutant is named as FAT(NV).
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Fig. 3. Isothermal titration calorimetry experiments of FAT(NKKV), FAT(NKKN) and FAT(NV) mutants interacting with LD1, LD2 and LD4 motifs.
Isothermal titration calorimetry curves (thermograms, upper plots; binding isotherms, lower plots) are shown for wild type and high affinity mutants of FAKFAT. This
includes V-like mutants (FAT(NKKN) and FAT(NKKV)) and FAT(NV) mutants interacting with (a) LD1 (b) LD2, and (c) LD4. Closed squares represent the experi-
mental data and continuous lines represent the non-linear least squares fitting curves.
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mutants (Fig. 4). The wild type showed an average turnover of
1.5× 10−3 μm2/s. Intriguingly, stable focal adhesions were observed in
cells expressing the FAK(NV) mutant, which has the slowest turnover
rate of 2.5× 10−5 μm2/s, while the cells expressing FAK(NKKV) have
the highest turnover of 3.5× 10−3 μm2/s. The cells expressing FAK
(NKKN) mutant have a focal adhesion turnover rate at 4.5× 10−4 μm2/
s. This finding suggests that the focal adhesion of cells expressing FAK
(NV) mutant are stable, while the focal adhesion of cells expressing FAK
(NKKV) mutant are more dynamic similar to those in wild type. Con-
sistent with ITC results, the remarkable higher affinity of FAK(NV)
mutant with Paxillin LD motifs resulted in high stability of the focal
adhesions.
4. Discussion
The regulated interaction of FAK and Paxillin at focal adhesions is
required for collective cell migration via down regulating Rac1 activity
[40,41], formation and maintenance of cadherin-based cell junctions in
migrating cells [42] and also for gene transcription [43]. Elevated ex-
pression of FAK is related to brain astrocytomas [44–46] and many
diseases [47]. FAK and Paxillin have been widely reviewed for their
potential as drug targets for treatment of various cancers [48–51]
which further emphasize the importance of studying their interaction.
By varying the relative position of single Lysine residues, nature has
wisely chosen to optimize the strength of protein-protein interactions
and thus downstream signaling. As shown in this study, moving Lysine
one helical turn in FAT(NKKV) mutant improved the binding affinity
while moving two helical turns (C-like mutants) did not make sig-
nificant differences. This showed that the Vinculin-like spatial ar-
rangement of the four residues is the most favorable arrangement. In
addition, the complementarity of charged surfaces and hydrophobic
interaction is a critical factor governing the affinity of these interac-
tions. This complementarity of charged surface can differentiate various
LD motifs although the key binding residues remains the same. Both
LD2 and LD4 preferred FAT(NKKN) mutation over FAT(NKKV) due to
better complementarity of the charged surfaces. The FAT(NKKN) mu-
tant suggested that even when Lysine residue is available for bonding
with Glu of LD4, the presence of another positively charged residue is
important, although the position of Lysine residue and Asparagine re-
sidues were interchangeable.
The complementarity of charged surface is exemplified by CCM3
also where the loss of interactions at pos4 lead to the tilted binding
conformation and thus reduced affinity for LD4. The relatively strong
binding of LD4 motif between helix2/helix3 of FAKFAT might be due to
optimal inter helical distance as compared to between helix1/helix4
interface and thus providing better complementarity. The positions of
Lysine residues are also relatively different and binding is additionally
satisfied via the contacts between Glu of LD4 with Lys and Asn (pos4),
Ser of LD4 with Lys (pos2), Thr of LD4 with Lys (pos1), and Ser with Lys
(pos3). LD2 binding at helix1/helix4 is satisfied by the interaction of
Histidine with Asn at the C-terminus of LD2 motif (distance 3.9 Å).
Similarly, the higher inter-helical distance in CCM3 as compared to
FAKFAT could have caused the reduced binding affinity of LD4 with
CCM3 and tilted binding conformation. The additional electrostatic
interactions similar to FAKFAT are missing in CCM3, thus resulting in a
weaker affinity for LD4. Such interactions resulting in better charge
complementarity are important factors for determining the binding
affinity and specificity. The optimal conformation also results in better
complementarity of hydrophobic surfaces and thus burial of hydro-
phobic residues of LD motif in the helical grove of FAKFAT domain. By
facilitating the improvement in complementarity, notably, a single
point mutation FAT(NV) is identified in this study that enabled LD1
peptide to bind to FAKFAT domain with very high affinity leading
to> 100 times stable focal adhesions.
LD2 and LD4 motifs can bind on two binding surfaces on FAKFAT at
the same time and presence of both binding sites on FAK can give 5–10
fold higher affinity with Paxillin [32,52]. In our experiment, LD1 binds
with high affinity to FAT(NV) in 2:1 ratio. We discuss that the LD1
binding to FAK(NV) mutant could have induced the sequential binding
of Paxillin LD motifs on two FAK(NV) surfaces, similar to simultaneous
binding of LD2 and LD4 motifs with wild type, although with much
higher binding affinity. Thus, the focal adhesions are highly stable in
MCF7 cells expressing FAT(NV) mutant. FAK(NKKN) mutant has higher
focal adhesion turnover rate compared to FAK(NV) mutant but lower
than wild type. This is explained by the fact that FAK(NKKN) mutant
exhibited higher affinities with three peptides (Kd= 48, 16, 10 re-
spectively) but with stoichiometry of 1 (Table 1). FAK(NKKV) shows
enhanced binding to LD1 and LD2 motifs with only 1:1 ratio (Table 3),
thus exhibits even higher turnover rate as that of the wild type which
exhibits two site binding. This suggests that sequential binding on two
sites of FAKFAT, induced by FAT(NV) mutation, is also critical for de-
termining overall focal adhesion turnover rate.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.bbagen.2019.129450.
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